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Angelman syndrome (AS) is associated with symp-
toms that include autism, intellectual disability,
motor abnormalities, and epilepsy. We recently
showed that AS model mice have increased
expression of the alpha1 subunit of Na/K-ATPase
(a1-NaKA) in the hippocampus, which was corre-
lated with increased expression of axon initial
segment (AIS) proteins. Our developmental analysis
revealed that the increase in a1-NaKA expression
preceded that of the AIS proteins. Therefore, we
hypothesized that a1-NaKA overexpression drives
AIS abnormalities and that by reducing its expres-
sion these and other phenotypes could be cor-
rected in AS model mice. Herein, we report that
the genetic normalization of a1-NaKA levels in AS
model mice corrects multiple hippocampal pheno-
types, including alterations in the AIS, aberrant
intrinsic membrane properties, impaired synaptic
plasticity, and memory deficits. These findings
strongly suggest that increased expression of
a1-NaKA plays an important role in a broad
range of abnormalities in the hippocampus of AS
model mice.INTRODUCTION
Angelman syndrome (AS) is a neurodevelopmental disorder
characterized by autism, mental retardation, absence of
speech, motor abnormalities, and epilepsy (Lossie et al.,
2001; Williams et al., 2006). In most cases, AS is caused
by the deletion of small portions on the maternal copy of
chromosome 15, which includes the UBE3A gene (Kishino
et al., 1997; Knoll et al., 1989; Matsuura et al., 1997; Sutcliffeet al., 1997). UBE3A encodes the ubiquitin ligase E3A (also
termed E6-AP), which covalently attaches polyubiquitin chains
to proteins, resulting in their degradation by the 26S protea-
some. AS model mice exhibit multiple levels of brain dys-
function that correlate with the neurological abnormalities
observed in humans, including cognitive deficits (Jiang et al.,
1998). For example, hippocampus-dependent long-term
memory and long-term potentiation (LTP), a cellular model
for learning and memory, have been shown to be impaired
in AS model mice (Jiang et al., 1998; van Woerden et al.,
2007).
Hippocampal CA1 pyramidal neurons in AS mice have
altered passive and active intrinsic membrane properties
(Kaphzan et al., 2011) that are correlated with the increased
expression of the a1 subunit of Na/K ATPase (a1-NaKA), the
voltage-gated sodium channel NaV1.6, and the axon initial
segment (AIS) protein ankyrin-G, as well as increased AIS
length (Kaphzan et al., 2011). In addition, it was shown that
the increased expression of a1-NaKA was developmental and
preceded the increased expression of NaV1.6 and ankyrin-G
(Kaphzan et al., 2011). It has been shown that increased
expression and activity of a1-NaKA lowers the resting mem-
brane potential and induces a less excitable state (Brodie
et al., 1987; Gadsby, 1984; Mallick et al., 2010; Silva et al.,
2006). Moreover, it was shown that disrupting presynaptic
input, which also decreases neuronal excitability, results in
AIS changes similar to what was observed in AS model mice
(Kuba et al., 2010). Therefore, we hypothesized that the
increased expression of a1-NaKA in AS mice induces a
decrease in neuronal excitability that drives changes at the
AIS in an effort to restore neuronal excitability to levels
observed in wild-type mice.
Here we report that genetic reduction of a1-NaKA prevents
the electrophysiological, biochemical, and morphological
abnormalities in the AIS in the hippocampus of AS model
mice. In addition, the genetic reduction of a1-NaKA corrects
impaired LTP and hippocampus-dependent memory deficits
displayed by the AS model mice. Our findings suggest thatCell Reports 4, 405–412, August 15, 2013 ª2013 The Authors 405
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Figure 1. Genetic Reduction of a1-NaKA Corrects Increased
Expression of Ankyrin-G and NaV1.6 in AS Model Mice
Western blot analysis of hippocampal homogenates from wild-type (WT),
Angelman syndrome (AS), a1-NaKA heterozygous knockout (a1-NaKA), and
AS/a1-NaKA heterozygous knockout (dKO) mice.
(A) Representative blots of ankyrin-G (480 kDa), NaV1.6, a1-NaKA, and actin.
(B) Cumulative data for the blots probed for a1-NaKA and actin.
(C) Cumulative data for the blots probed with antibodies to ankyrin-G
and actin.
(D) Cumulative data for the blots probed for NaV1.6 and actin.
For all panels, actin was used as a loading control and quantification was done
as a ratio to wild-type on the same blot (WT: n = 6; AS: n = 7; a1-NaKA: n = 7;
dKO: n = 7). Asterisks (*p < 0.05 and **p < 0.01) denote statistical significance
from wild-type (ANOVA followed by Tukey’s post-hoc test). Results are dis-
played as mean ± SEM.increased expression of a1-NaKA in early development involves
altered intrinsic membrane properties, AIS pathology, impaired
synaptic plasticity, and cognitive deficits in the hippocampus
of AS model mice.406 Cell Reports 4, 405–412, August 15, 2013 ª2013 The AuthorsRESULTS
Genetic Reduction of a1-NaKA Levels Corrects
Increases in the Expression of Ankyrin-G and NaV1.6 in
the Hippocampus of AS Mice
In AS mice, increased expression of a1-NaKA preceded the
increased expression of the AIS-related proteins, and in regions
where a1-NaKA expression was not increased, the AIS was
unaltered (Kaphzan et al., 2011). Therefore, we hypothesized
that the increased expression of a1-NaKA drives the AIS alter-
ations in the AS mice. To test this hypothesis, we bred female
mice that carried the deletion of Ube3A from a paternal origin
(Ube3A+/ (m/p)) (so that the behavior of these females would
not be affected) with male mice that were heterozygous for the
deletion of a1-NaKA (a1-NaKA+/ (m/p)). This breeding strategy
resulted in four distinct genotypes: wild-type, Ube3A/+ (m/p)
(AS), a1-NaKA+/ (m/p) (a1NaKA), and Ube3A/+ (m/p)/a1-
NaKA+/ (m/p) double-knockout (dKO) mice.
First, we confirmed that the expression of a1-NaKA was
reduced in the dKO progeny resulting from crossing the AS mice
with a1-NaKA heterozygous knockout mice (Figures 1A and 1B).
We then proceeded to determine whether reducing a1-NaKA
levels could prevent the increase in AIS-related protein levels in
the AS mice. We found that the genetic reduction of a1-NaKA
expression prevented the increased expression of both ankyrin-G
and NaV1.6 in AS mice, restoring them to levels observed in
wild-typemice (Figures 1C and 1D). These findings are consistent
with the idea that the increased expression of a1-NaKA leads to
increases in the expression of ankyrin-G and NaV1.6.
AIS Length in CA1 and CA3 Pyramidal Neurons in the
Hippocampus of AS Mice Is Normalized by Genetic
Reduction of a1-NaKA Levels
The normalization of NaV1.6 and ankyrin-G levels in AS mice to
those observed in wild-type mice by reducing a1-NaKA ex-
pression led us to determine the AIS length in the dKO mice.
Consistent with the correction in ankyrin-G and NaV1.6 protein
expression, the length of the AIS in hippocampal CA1 and CA3
pyramidal neurons in the ASmice with the heterozygous deletion
of a1-NaKA was similar to that observed in wild-type mice (Fig-
ures 2A and 2B). The length of the AIS in hippocampal CA1 and
CA3 pyramidal neurons in the a1-NaKA heterozygous knockout
mice was unaltered relative to their wild-type counterparts. We
previously reported that AIS length in the somatosensory cortex
of AS mice was similar to that in wild-type littermates (Kaphzan
et al., 2011). Here we found that the AIS length of neurons in
the somatosensory cortex did not differ among the four geno-
types (Figure 2C). These results suggest that increased ex-
pression of a1-NaKA leads not only to increased expression of
AIS-related proteins but also alterations in AIS morphology in
the hippocampus of AS mice.
Genetic Reduction of a1-NaKA Levels Corrects Altered
Intrinsic Membrane Properties in Hippocampal CA1
Pyramidal Neurons in AS Mice
The increased expression of AIS-related proteins and the
increase in AIS length in AS mice are correlated with altered
intrinsic membrane properties in hippocampal pyramidal
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Figure 2. AIS Length in AS Model Mice Is
Restored to Wild-Type Length in Hippo-
campal CA1 and CA3 Pyramidal Neurons
by Genetically Reducing a1-NaKA Levels
(A–C) Immunostaining analysis of ankyrin-G
expression and AIS length in hippocampal and
cortical tissue from wild-type (WT), Angelman
syndrome (AS), a1-NaKA heterozygous knockout
(a1-NaKA), and AS/a1-NaKA heterozygous
knockout (dKO) mice. Coronal brain slices con-
taining the hippocampal formation and somato-
sensory cortex were immunostained with
antibodies targeted against ankyrin-G. AIS length
was quantified in CA1 (A), CA3 (B), and layer II/III
somatosensory cortex (C) in tissue from each of
the four genotypes. WT: n = 240 cells per region, 2
mice; AS: n = 239 cells per region, 2 mice;
a1-NaKA: n = 240 cells per region, 2 mice; dKO:
n = 239 cells per region, 2 mice. Average, region-
specific AIS length data are provided in box and
whisker plots. ***p < 0.001 (ANOVA). Fluorescence
intensity (F.I.) plots provide a comparison of
representative AIS ankyrin-G immunosignal
strength and AIS length of cells contained in the
expanded views, shown to the right of the
contextual image.neurons (Kaphzan et al., 2011). Therefore, we determined
whether the genetic reduction of a1-NaKA could correct the
altered intrinsic membrane properties in the AS mice. We found
that each of the intrinsic properties that were shown to be altered
in the AS mice, including resting potential, threshold potential,
action potential amplitude, and the action potential maximal
rate of rise, were corrected to wild-type values in the dKO
mice (p < 0.001, ANOVA for all of the intrinsic values measured)
(Figures 3A, 3D, 3E, and 3G). Other intrinsic properties that were
unaltered in AS mice, including membrane time constant, input
resistance, full width of action potential at half-maximum, and
rheobase, remained unchanged with the heterozygous deletion
of a1-NaKA (Figures 3B, 3C, 3F, and 3H). a1-NaKA heterozygous
knockout mice exhibited intrinsic properties that were indistin-
guishable from wild-type mice. Examples of the traces of the ac-
tion potentials and their derivative (as described in Experimental
Procedures) for determining the action potential threshold, peak
and maximal rate of rise are displayed in Figures S1A and S1B,Cell Reports 4, 405–412and sample traces of current injections
for acquisition of action potentials are
shown Figure S1D. These results indicate
that the genetic reduction of a1-NaKA
corrects altered intrinsicmembrane prop-
erties of hippocampal pyramidal neurons
in AS mice.
Hippocampal Synaptic Plasticity
andMemory Impairments Exhibited
by ASMice Are Rescued by Genetic
Reduction of a1-NaKA Levels
We next determined whether the genetic
reduction of a1-NaKA could correct twoof the most robust hippocampal phenotypes displayed by the
AS mice: impaired LTP and deficits in long-term memory (Jiang
et al., 1998; van Woerden et al., 2007). Consistent with previous
findings, we found that LTP was impaired in hippocampal slices
from AS mice (Figure 4A). The impaired LTP in AS mice could be
completely prevented by the heterozygous deletion of a1-NaKA
(Figure 4A). a1-NaKA heterozygous knockout mice exhibited
LTP comparable to that observed in wild-type mice (Figures 4A
and 4B). Paired-pulse facilitation in the dKO mice before and
after HFS was similar (Figure S2A), suggesting that the correc-
tion of LTP was achieved via a postsynaptic mechanism. These
results indicate the genetic reduction of a1-NaKA can correct
impaired hippocampal synaptic plasticity in AS mice.
We proceeded to examine long-term hippocampus-depen-
dent memory in the dKO mice using contextual fear and Morris
water maze (MWM) tests. The acquisition of the fear memory
was similar among all four genotypes (Figure S2B), suggesting
that sensory perception did not differ among the four genotypes., August 15, 2013 ª2013 The Authors 407
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Figure 3. Genetic Reduction of a1-NaKA Cor-
rected Alterations in the Intrinsic Membrane
Properties of Hippocampal CA1 Pyramidal
Neurons in AS Model Mice
(A–H) Intrinsic membrane properties of hippocampal
CA1 pyramidal neurons in WT, AS, a1-NaKA hete-
rozygous knockout (a1-NaKA), and dKO mice
measured by current clamp without current injection
(I = 0).
(A) Resting membrane potential.
(B) Membrane time constant.
(C) Membrane input resistance.
(D) Threshold potential.
(E) Action potential amplitude.
(F) Action potential full width at half-maximum.
(G) Maximal rate of rise (dV/dt) of the action potential.
(H) Rheobase (amount of current injection needed to
induce an action potential at the 5 ms time point).
WT: n = 28 cells, 8 mice; AS: n = 28 cells, 8 mice;
a1-NaKA: n = 24 cells, 7 mice; dKO: n = 27 cells,
8 mice. ***p < 0.001 (ANOVA). Results are displayed
as mean ± SEM. See also Figure S1.Importantly, genetic reduction of a1-NaKA completely pre-
vented long-term contextual fear memory deficits displayed by
the ASmice (Figures 4C and 4D). Likewise, the genetic reduction
of a1-NaKA prevented spatial memory deficits displayed by the
AS mice in the MWM (Figures 4E and 4F). Escape latency times
in the visible platform test were similar for all groups (Figure S3A),
as was swim speed (Figure S3B) and distance traveled (Fig-
ure S3C). It should be noted that the a1-NaKA heterozygous
knockout mice did not display deficits in either contextual fear
or spatialmemory tests (Figures4C, 4D,4E, 4F, andS2C), consis-
tent with previously published behavioral studies of these mice
(Lingrel et al., 2007; Moseley et al., 2007). In addition, all groups
performed similarly in an open field test (Figures S3D and S3E).
Finally, novel object recognition memory, which is context and
hippocampus independent (Barker and Warburton, 2011; For-
wood et al., 2005; Good et al., 2007; Langston and Wood,
2010), was normal in ASmice and was not altered by the genetic
reduction of a1-NaKA (Figure S3F). Taken together, these find-
ings suggest that increased expression of a1-NaKA in the408 Cell Reports 4, 405–412, August 15, 2013 ª2013 The Authorshippocampus during development contrib-
utes to long-term hippocampus-dependent
memory deficits displayed by AS mice.
DISCUSSION
We previously showed that there is an
increase in the expression of a1-NaKA that
is correlatedwithmolecular andmorpholog-
ical changes in the AIS, including increased
expression of NaV1.6 and ankyrin-G and
increased AIS length, in the hippocampus
of AS model mice (Kaphzan et al., 2011).
We also found that the AS mice exhibited
various alterations in intrinsic membrane
properties (Kaphzan et al., 2011). Because
we found that the increased expression ofa1-NaKA in the AS mice is correlated with altered intrinsic
membrane properties (Figure S1) and precedes the increases
in AIS-related protein levels, we hypothesized that the increase
in a1-NaKA levels is the driving force for the alterations in the
AIS and intrinsic membrane properties.
Consistent with our hypothesis, we found that genetically
reducing the level of a1-NaKA in the AS mice corrected multiple
AIS phenotypes in the hippocampus. The increase in expression
of the AIS-related proteins NaV1.6 and ankyrin-G in the AS mice
was reduced to wild-type levels (Figure 1). In addition, the
increase in AIS length in areas CA1 and CA3 of the AS mice
was decreased to the length observed in wild-type mice in the
dKO mice (Figure 2). Moreover, the altered intrinsic membrane
properties in the AS mice that are related to AIS composition
and morphology were corrected to those observed in wild-type
mice (Figure 3). Taken together, these findings are consistent
with the notion that the increased expression of a1-NaKA is
one of the events early in development that causes AIS pathol-
ogy and altered intrinsicmembrane properties in ASmodel mice.
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Figure 4. Genetic Reduction of a1-NaKA
Corrects Deficits in Hippocampal LTP,
Contextual Fear Memory, and Spatial
Memory Displayed by AS Mice
(A) Hippocampal slices from WT, AS, a1-NaKA
heterozygous knockout mice (a1-NaKA) and dKO
mice were stimulated with two trains of high-
frequency stimulation (HFS, indicated by the
arrows). WT: n = 10 slices, 5 mice; AS: n = 10
slices, 5 mice; a1-NaKA: n = 10 slices, 5 mice;
dKO: n = 16 slices, 8 mice. p < 0.05 for group, p <
0.0001 for time, and p < 0.0001 for interaction
(RM-ANOVA).
(B) Sample traces of typical field excitatory post-
synaptic potentials (fEPSPs) recorded before
(black) and 60 min after (red) HFS.
(C) Mice were trained using a standard contextual
fear conditioning paradigm and tested for long-
term memory measured as % time freezing seven
days after training. WT: n = 12 mice; AS: n = 11
mice; a1-NaKA: n = 11 mice; dKO: n = 11 mice.
Results are displayed as the average of percent
freezing during the entire 5 min test. ***p < 0.001
(ANOVA followed by Tukey’s post-hoc test).
(D) Results are displayed as percent freezing along
the entire test, minute by minute. ***p < 0.001 for
interaction of group and treatment (RM-ANOVA).
(E) Mice were trained using a standard Morris
water maze paradigm and tested for spatial
memory of platform location in the probe test
(platform removed). n = 8 for WT, AS, and dKO; n =
5 for a1-NaKA. Results are displayed as percent-
age of time spent in each quadrant along the entire
probe test (quadrant time occupancy). p < 0.05 for
interaction of genotype and quadrant (two-way
ANOVA); **p < 0.01 for the trained quadrant
(Bonferroni post-hoc test).
(F) Results are displayed as a number of platform
location crosses during the probe test. **p < 0.01
(ANOVA followed by Tukey’s post-hoc test).
Results are displayed as mean ± SEM. See also
Figures S2 and S3.The mechanism by which the genetic reduction of a1-NaKA
prevents the increased expression of the AIS-related proteins
and the abnormal AIS morphology in the absence of E6-AP ac-
tivity remains unresolved; however, several mechanisms can
be considered. It previously was shown that ablating presynaptic
input, which induces a decrease in neuronal excitability, results
in AIS alterations that resemble the alterations we observed in
the AS mice hippocampus (Kuba et al., 2010). These AIS alter-
ations were hypothesized to be feedback responses that
normalize overall neuronal excitability, consistent with the
homeostatic model of the neuron (Turrigiano and Nelson,
2004). In the AS mice, the increased expression of a1-NaKA
would be predicted to decrease excitability by inducing hyper-
polarization. Thus, decreased excitability in the AS mice could
trigger the observed compensatory changes in the AIS that are
aimed at increasing excitability. However, other mechanisms
also are possible, such as changes in signal transduction cas-
cades that could result in altered expression of various proteins
(Figure 1) or altered network plasticity in AS mice that arerestored by reducing a1-NaKA (Figure 4). Future studies in AS
mice are needed to further dissect these potential mechanisms.
We believe the current study is important beyond its relevance
to AS because it broadens our understanding of AIS plasticity.
These studies demonstrate that a genetic manipulation can
induce long-term structural plasticity of the AIS. Furthermore,
our studies suggest a potential mechanism by which a single
molecular change, increased a1-NaKA expression, can induce
AIS alterations similar to those observed by blocking presynaptic
input (Kuba et al., 2010). Thus, the demonstration that increased
expression of a1-NaKA can alter AIS structure and function adds
another tier to our understanding of AIS plasticity.
In addition to the correction of abnormalities in the AIS and
intrinsic membrane properties, we demonstrated that impaired
hippocampal LTP and hippocampus-dependent memory defi-
cits also were corrected by genetically reducing a1-NaKA
expression in the AS mice (Figure 4). Whether the correction of
the synaptic plasticity and memory deficits is the consequence
of reversing the AIS pathology and/or alterations in intrinsicCell Reports 4, 405–412, August 15, 2013 ª2013 The Authors 409
membrane properties remains to be determined. a1-NaKA is a
molecule that is localized in multiple subcellular compartments
and affects numerous cellular functions. Hence, it also is
possible that the increase in a1-NaKA expression in the AS
mice is a key event related to hippocampal deficits via molecular
and cellular alterations other than the AIS. Alternatively, it also is
possible that the reduction of a1-NaKA expression rescues hip-
pocampal deficits in the AS mice via a different compensatory
mechanism.
The clinical significance of the results reported here may
extend beyond AS to other classes of psychiatric and develop-
mental disorders. There are a number of studies in the clinical
literature that link various psychiatric disorders to either NaKA
activity or expression (Al-Mosalem et al., 2009; Chetcuti et al.,
2008; Corti et al., 2011; Goldstein et al., 2006; Ji et al., 2009).
Furthermore, AIS-specific changes have been identified in
superficial pyramidal neurons in postmortem analysis of tissue
from human subjects with schizophrenia (Cruz et al., 2009).
Thus, it is possible that alterations in neuronal excitability and
the AIS in animal models of multiple psychiatric disorders
previously were overlooked and now should be examined.
Such studies may improve our understanding of neuropsychi-
atric pathology and suggest additional therapeutic approaches
for these disorders.
EXPERIMENTAL PROCEDURES
Mice
Mice for experiments were bred from a female that was heterozygous for the
deletion ofUbe3a from a paternal origin (Ube3ap/m+) and an a1-NaKA hetero-
zygous male (a1-NaKAp/m+). Both parents were on a C57/Bl6 background.
For all experiments, mice used were 8–12 weeks of age (unless otherwise
specified), and for all experiments littermates were used as controls. Mice
were genotyped using specific primers as described previously (Jiang et al.,
1998; James et al., 1999). All mice were housed in the Transgenic Mouse
Facility of New York University, compliant with the NIH Guide for Care and
Use of Laboratory Animals. Mice were kept on a 12 hr light/dark cycle, with
food pellets and water ad libitum.
Tissue Preparation for Western Blots
Mice were decapitated, the brain was quickly extracted, and hippocampi from
both hemispheres were removed in an ice-cold cutting solution (CS) contain-
ing (in mM) 110 sucrose, 60 NaCl, 3 KCl, 1.25 NaH2PO4, 28 NaHCO3, 0.5
CaCl2, 7 MgCl2, 5 glucose, and 0.6 ascorbate, and immediately snap-frozen
on dry ice. Frozen hippocampi were placed in ice-cold lysis buffer containing
(in mM) 40 HEPES (pH 7.5), 150 NaCl, 10 pyrophosphate, 10 glycerophos-
phate, 1 EDTA and 0.3% CHAPS, and protease inhibitor (Protease Inhibitor
II and Phosphatase Inhibitor Cocktail I, II [Sigma]) and homogenized by soni-
cation. Protein quantification was carried out with bicinchoninic acid protein
assay reagent (Thermo Scientific).
Western Blots
After homogenization and protein quantification, protein samples were added
to b-mercaptoethanol-containing SDS sample buffer and heated for 2 min in
60C prior to loading on SDS-polyacrylamide gels. After heating the samples,
4–20 mg of protein (depending on the specific protein and the linear range of
detection) were loaded on 4%–12%gradient SDS-PAGE gels, resolved, trans-
ferred to polyvinylidene fluoride membranes, and probed with primary anti-
bodies using standard techniques. The primary antibodies and the dilutions
for the western blots used in these studies are as follows: NaV1.6 1:500
(Sigma-Aldrich); a1-NaKA (clone C464.6) 1:1,000 (Millipore); ankyrin-G
1:1,000, b-actin and GAPDH 1:5,000 (Santa Cruz Biotechnology). Secondary
antibodies were conjugated with horseradish peroxidase. All blots were devel-410 Cell Reports 4, 405–412, August 15, 2013 ª2013 The Authorsoped using enhanced chemiluminescence detection (GE Healthcare). The
bands of each western blot were imaged and quantified using the KODAK
4000MM imaging system. All signals were obtained in the linear range for
each antibody, normalized by total protein, and quantified via densitometry.
Data represent mean ±SEM. ANOVA was used for western blot analysis with
p < 0.05 as significance criteria.
Intracellular Electrophysiology
Brains from the four mouse genotypes were quickly removed and transverse
hippocampal slices (300 mm) were isolated with a Leica VT1200 Vibratome
(Leica). Slices were cut in ice-cold cutting solution containing (in mM) 110
sucrose, 60 NaCl, 3 KCl, 1.25 NaH2PO4, 28 NaHCO3, 0.5 CaCl2, 7 MgCl2, 5
glucose, and 0.6 ascorbate. Slices were recovered for 45 min at 36C in artifi-
cial cerebrospinal fluid (ACSF) containing (in mM) 125 NaCl, 2.5 KCl, 1.25
NaH2PO4, 25 NaHCO3, 25 D-glucose, 2 CaCl2, and 1 MgCl2 ACSF, followed
by additional recovery for 30 min in room-temperature ACSF. After initial
recovery, slices were placed in a submerged chamber and maintained at
36C in ACSF (2 ml/min). Slices were allowed to recover for an additional
60 min on the electrophysiology rig prior to experimentation. All solutions
were constantly caboxygenated with 95% O2 + 5% CO2. Hippocampal CA1
pyramidal cells were illuminated and visualized using a 360 water-immersion
objective mounted on a fixed-stage microscope (BX51-WI; Olympus), and the
image was displayed on a video monitor using a charge-coupled device
camera (Hamamatsu). Recordings were amplified by multiclamp 700B and
digitized by Digidata 1440 (Molecular Devices). The recording electrode was
pulled from a borosilicate glass pipette (3–5 MU) using an electrode puller
(P-97; Sutter Instruments) and filled with a K-gluconate-based internal solution
containing (in mM) 120 K-gluconate, 20 KCl, 10 HEPES, 2 MgCl2, 4 Na2ATP,
0.5 TrisGTP, 14 phosphocreatine, osmolarity 290 mOsm, and pH 7.3. The
recording glass pipettes were patched onto the CA1 pyramidal cells soma
region. Voltages for liquid junction potential (+14 mV) were not corrected
online. All current-clamp recordings were low-pass filtered at 10 kHz and
sampled at 50 kHz. Series resistance was compensated and only series resis-
tance <20 MU was included in the data set. Pipette capacitance was 99%
compensated. Themethod formeasuring active intrinsic properties was based
on a modified version of Kole and Stuart (2008). After initial assessment of the
current, which was required to induce an action potential at 15 ms from the
start of the current injection with large steps (50 pA), we injected a series of
brief depolarizing currents for 10 ms in steps of 10 pA increments. The first
action potential that appeared on the 5 ms time point was analyzed. A curve
of dV/dt was created for that trace, and threshold was considered as the 30
V/s point in the rising slope of the action potential. Series resistance, input
resistance, and membrane capacitance were monitored during the entire
experiment. Changes in these parameters (which were monitored throughout
the entire duration of the experiment) bigger than 10% were criteria for
exclusion of data. Data analysis was done with Clampfit (Molecular Devices,
Sunnyvale, CA). ANOVA was used for electrophysiological data analysis with
p < 0.05 as significance criteria.
Extracellular Electrophysiology
Hippocampal slices were prepared using the same procedure used for whole-
cell recordings, except that the slice thickness was altered (400 mm). Slices
were allowed to recover for 20 min at room temperature in 50:50 CS:ACSF
containing (in mM) 125 NaCl, 2.5 KCl, 1.25 NaH2PO4, 25 NaHCO3, 25
D-glucose, 2 CaCl2, and 1 MgCl2 ACSF, followed by additional recovery for
30 min in room-temperature ACSF. After initial recovery, slices were placed
in an interface chamber (Scientific Systems Design) and maintained at 33C
in ACSF (2 ml/min). Slices were allowed to recover for an additional 120 min
on the electrophysiology rig prior to experimentation. All solutions were
constantly caboxygenated with 95% O2 + 5% CO2. Bipolar stimulating elec-
trodes (92:8 Pt:Y) were placed at the border of area CA3 and area CA1 along
the Schaffer-Collateral pathway. ACSF-filled glass recording electrodes (1–3
MU) were placed in stratum radiatum of area CA1. Basal synaptic transmission
was assessed for each slice by applying gradually increasing stimuli (0.5–15V)
using a stimulus isolator (A-M Systems) and determining the input:output rela-
tionship. All subsequent stimuli applied to slices was equivalent to the level
necessary to evoke a field excitatory postsynaptic potential (fEPSP) that was
25%–35% of the maximal initial slope that could be evoked. Synaptic efficacy
was continuously monitored (0.05 Hz). Sweeps were averaged together every
2 min. fEPSPs were amplified (A-M Systems Model 1800) and digitized
(Digidata 1440; Molecular Devices) prior to analysis (pClamp; Molecular
Devices). Stable baseline synaptic transmission was established for at least
60 min. Slices were given high-frequency stimulation (HFS) to induce LTP
using two trains of 100 Hz for 1 s, with an interval of 20 s between each train.
Stimulus intensity of the HFSwas matched to the intensity used in the baseline
recordings. The initial slopes of the fEPSPs from averaged traces were normal-
ized to those recorded during baseline. RM-ANOVAs were used for electro-
physiological data analysis with p < 0.05 as significance criteria.
Contextual Fear Conditioning
Mice were handled for 3 consecutive days (10 min/day) prior to experimenta-
tion. On the day of the behavioral assays, the mice were habituated for at least
30min to the testing room. On the conditioning day, eachmouse was placed in
the chamber and received two foot-shocks (0.5 mA intensity, 2 s duration,
1 min interval) starting after 2 min of free exploration. The contextual memory
test was performed 7 days later by placing each mouse back into the same
conditioning chamber for 5 min. Freezing behavior, defined as a lack of move-
ment except those involved in respiration, was measured using video files that
were analyzed by an observer blind to mouse genotype and treatment.
Freezing behavior during conditioning was assessed four times during the
5 min period: 2 min exploration before the first shock and then every minute
interval (i.e., after the first foot shock, after the second foot shock, and during
the last minute). Freezing behavior during contextual memory test was
assessed every minute along the 5 min period. Freezing time was converted
to percent freezing by the formula [duration of freezing (s) in the time inter-
val/time of the interval (s)] 3 100. Data were analyzed with repeated-measure
ANOVA, using either time or interval as the within-subject factor and genotype
and treatment as the between-subject variable. ANOVA was used to analyze
the total average percent freezing during the contextual memory test.
Immunostaining
Mice were deeply anesthetized with isoflurane before transcardial perfusion
with ice-cold 4% PFA in 0.1M Na-phosphate buffer (PB; pH 7.2). Brains
were postfixed in 4% PFA 0.1M PB for 1 hr and equilibrated in 20% sucrose
0.1M PB over 48 hr. Afterward, 25 mm coronal slices containing the hippo-
campal formation were cut on a microtome and washed in 0.1M PB. Slices
were mounted on gelatin-coated coverslips, then blocked in 10% normal
goat serum 0.1M PB containing 0.3% TX-100 (PBTgs). Tissue was incubated
overnight at 4C in primary antibodies diluted in PBTgs. Primary antibodies
were removed by washing the tissue 3 times for 5 min with PBTgs.
Alexa594-conjugated goat anti-mouse (1:1,000) secondary antibodies diluted
in PBTgs were applied for 1 hr at RT and used to visualize primary antibodies.
Fluorescent dye-conjugated secondary antibodies were purchased from Invi-
trogen. Excess secondary antibodies were removed by consecutive 5 min
washes with PBTgs, 0.1M PB, and 0.05MPB. Fluorescence imaging was per-
formed on an AxioImager Z1 microscope (Carl Zeiss MicroImaging) fitted with
an AxioCam digital camera (Carl Zeiss MicroImaging). AxioVision acquisition
software (Carl Zeiss MicroImaging) was used for collection of images. Com-
parison of wild-type and AS tissuewas performed on slices prepared in parallel
and images were acquired at identical exposure times. Experiments were
performed at least in triplicate. Fluorescence intensity was measured using
ImageJ (NIH). No additional processing of images was performed.
Antibodies for Immunostaining
The primary antibody that was used is mouse anti-ankyrin-G (NeuroMab,
clone N106/36). Alexa Fluor 594-conjugated goat anti-mouse secondary anti-
bodies (Invitrogen) were used to visualize the ankyrin-G antibodies.
AIS Length Quantification
AIS length was determined by line-scan length quantification of ankyrin-G
immunosignal in Image J (NIH). For quantification, we measured the length
of AIS contained within either a single image plane or through three-dimen-
sional space in consecutive z stack images. Anti- ankyrin-G immunosignal
was uniformly distributed throughout the AIS, providing a stark contrast in fluo-rescence intensity values at the axon hillock to AIS and AIS to distal axon tran-
sitions. Thus, to determine AIS length, we generated fluorescence intensity
plots of ankyrin-G immunoreactivity and calculated the first derivative of the
resulting intensity curve. The start and end points of the AIS were defined as
the maximum and minimum values, respectively, of the derivative curve.
Statistical Analysis
ANOVA (one way and repeated measures) were used where appropriate.
Results are displayed as mean ± SEM.
For further details, please refer to the Extended Experimental Procedures.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
three figures and can be found with this article online at http://dx.doi.org/10.
1016/j.celrep.2013.07.005.
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